Media Highlights

Top 10 innovations in podiatric care

News Outlet: 
Podiatry Today
Date published: 
July 1, 2010

HudsonAlpha resident associate company Diatherix Laboratories' Tem-PCR technology was noted as one of the top 10 recent innovations in podiatric care. Senior editor Bryan McCurdy writes of Diatherix:

New Lab Test May Diagnose Infection Faster

Product discovery & development: Targeting ovarian

News Outlet: 
BioCentury: the Bernstein Report on BioBusiness
Date published: 
June 21, 2010
Download PDF: 

HudsonAlpha resident associate EGEN was featured recently in BioCentury: the Bernstein Report on BioBusinessBioCentury, a respectable publication in drug development, provides news and analyses of existing and future pharmaceutical products.  The publication has described EGEN-001 as a promising future product for ovarian cancer.  EGEN presented its clinical trial data in last month’s meeting of American Society of Clinical Oncology.  

BioTrain program gets interns ready for biotech careers

News Outlet: 
The Huntsville Times
Date published: 
June 14, 2010
Download PDF: 

By Budd McLaughlin

HUNTSVILLE, Ala. - After lunch today, about two dozen interns at HudsonAlpha Institute for Biotechnology will be unleashed into the world of biotech research.

The group - which includes high school, undergrad and grad students - wrapped up a one-week "biotech boot camp" Friday under the tutelage of Dr. Bob Zahorchak , the administrator of intern activities at HudsonAlpha.

HudsonAlpha celebrates 'Power of Thought'

News Outlet: 
The Huntsville Times
Date published: 
April 24, 2010
Download PDF: 

By Budd McLaughlin

A bronze statue of an athletic figure greets visitors to the HudsonAlpha Institute for Biotechnology in Cummings Research Park.

Entitled the "Power of Thought," the sculpture by Victor Issa is reflective of the work going on behind it.


On Friday, the public was invited to see what is going on behind the scenes at HudsonAlpha.


The third annual DNA Day featured tours of the facility, hands-on learning with DNA extractions, a new lab entitled Risky Business and a DNA art exhibition.

Fifteen area companies named Best Places to Work in annual awards

News Outlet: 
The Huntsville Times
Date published: 
April 20, 2010

By Marian Accardi

Fifteen area companies were presented Best Places to Work awards Tuesday at the third annual event hosted by the Huntsville/Madison County Chamber of Commerce and the North Alabama Society for Human Resource Management.

Space-age medicine from the Rocket City

News Outlet: 
The Decatur Daily
Date published: 
April 18, 2010
Download PDF: 

By Eric Fleischauer
Staff Writer

You visit the doctor with lungs rattling and nose dripping.

A drum thumps in your head.

You want to know exactly what is causing the symptoms, but until a recent development at Huntsville’s HudsonAlpha Institute of Biotechnology, you had to rely heavily on how well your doctor could play the odds.

International network of cancer genome projects

News Outlet: 
Nature
Date published: 
April 15, 2010
Download PDF: 

HudsonAlpha is a member of international network of cancer genome projects.

Rx for animal testing

News Outlet: 
The Huntsville Times R&D Report
Date published: 
April 14, 2010
Download PDF: 

HudsonAlpha resident associate company CFDRC was featured in a Spring 2010 R&D Report article.

Download and read the article above.

Huntsville-based HudsonAlpha offers breakthrough in biology education

News Outlet: 
The Huntsville Times
Date published: 
April 12, 2010
Download PDF: 

By Budd McLaughlin

Contrary to the way most of us were taught in school, cells (plants, animals and bacteria) are not flat.

Perhaps we knew that they weren't, but there wasn't any way for us to see that because the diagrams were usually presented on pages in textbooks.

Surprise Finding Points to Next-Gen Sequencing's Utility for Vaccine Quality Control

News Outlet: 
GenomeWeb Daily News
Date published: 
April 6, 2010

By Monica Heger

Researchers expecting to demonstrate with next-generation sequencing that live attenuated viral vaccines contain only known viral genomes were recently surprised to discover a prevalent and nonpathogenic pig virus in GlaxoSmithKline's rotavirus vaccine Rotarix — a finding that raised questions about the safety of the vaccine while also highlighting sequencing's potential as a quality-control tool in vaccine development. Although not yet a common quality control tool, some biologics safety testing companies such as BioReliance, are already offering that service to pharmaceutical and biotech companies.